B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 29.75 SEK 0.51% Market Closed
Market Cap: 2B SEK

Wall Street
Price Targets

BINV Price Targets Summary
BioInvent International AB

Wall Street analysts forecast BINV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BINV is 78.2 SEK with a low forecast of 60.6 SEK and a high forecast of 94.5 SEK.

Lowest
Price Target
60.6 SEK
104% Upside
Average
Price Target
78.2 SEK
163% Upside
Highest
Price Target
94.5 SEK
218% Upside
BioInvent International AB Competitors:
Price Targets
NBIX
Neurocrine Biosciences Inc
24% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
OXB
Oxford BioMedica PLC
24% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
63% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
37% Upside
XNCR
Xencor Inc
87% Upside
DVAX
Dynavax Technologies Corp
38% Upside
KURN
Kuros Biosciences AG
28% Upside

Revenue
Forecast

Revenue Estimate
BioInvent International AB

For the last 13 years the compound annual growth rate for BioInvent International AB's revenue is -8%. The projected CAGR for the next 3 years is 134%.

-8%
Past Growth
134%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioInvent International AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
BioInvent International AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BINV's stock price target?
Price Target
78.2 SEK

According to Wall Street analysts, the average 1-year price target for BINV is 78.2 SEK with a low forecast of 60.6 SEK and a high forecast of 94.5 SEK.

What is BioInvent International AB's Revenue forecast?
Projected CAGR
134%

For the last 13 years the compound annual growth rate for BioInvent International AB's revenue is -8%. The projected CAGR for the next 3 years is 134%.

Back to Top